06.06.2023 14:24:54
|
Phil, Teva Partner To Help Patients To Receive, Refill Digihaler Medication
(RTTNews) - Phil Inc. announced an agreement with Teva Pharmaceuticals that will make Digihaler products available for prescription using the PhilRx Patient Access Platform. Teva's Digihaler system is the first smart inhaler system that can provide objective inhaler data to help patients and their doctors have informed treatment discussion in support of asthma management.
Using the PhilRx Patient Access Platform, patients can fill their prescription, review prescription records and obtain assistance navigating insurance benefits. Also, physicians can select the PhilRx Patient Access Platform directly from an electronic medical record to submit a prescription for a Digihaler product.
For More Such Health News, visit rttnews.com.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Teva Pharmaceutical Industries Ltd. (spons. ADRs)mehr Nachrichten
Analysen zu Teva Pharmaceutical Industries Ltd. (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 16,55 | -0,30% |
|